· discovered in 1940's
· derived from soil bacteria
· effective against vast majority of gram-negative bacilli
· multifactorial bacteriocidal effect
· bind to gram-negative bacterial cell wall and affect permeability
· actively taken up and concentrated by bacteria
· bind to bacterial ribosomes and affect protein synthesis
· concentration-dependent killing
· one single bolus dose works better than divided doses in 24 hrs
· persistent suppression of bacterial growth after short antimicrobial exposure
· continues for 2-3 hrs after exposure to aminoglycoside removed
· concentration-dependent
· synergy between aminoglycoside and cell wall active microbial (penicillin, cephalosporin) for gram-positive cocci
· administered IV over 30 min or IM (completely absorbed in 30-90 min)
· minimal absorption from GIT
· wide volume of distribution
· poorly protein bound and very water soluble
· cross membranes poorly
· traverse blood-brain barrier poorly
· exception is renal tubular and inner ear cells
· enters synovial fluid easily
· not metabolised
· 99% excreted unchanged in kidney
· allergies rare
· can cause
· injury to renal proximal convoluted tubules
· damage to cochlea and vestibular apparatus
· appears to be less with once-daily dose
· aerobic G- bacillus
· Klebsiella
· Enterobacter
· Serratia
· Pseudomonas aeruginosa (tobramicin)
· aerobic G+ cocci
· Strep viridans
· Staph aureus (methicillin sensitive)
· Staph epidermidis
· Enterococcus
· with penicillin or cephalosporin
· resistance rare
· loading dose of 2 mg/kg and then 1.7 mg/kg q8h
· aim for peak of 4-10 and trough of < 2
· clinical data not adequate to support unqualified endorsement
Premise
· nephrotoxicity and ototoxicity less severe
· PAE demonstrated which is peak concentration-dependent
· antibacterial efficacy enanced with high peak drug concentration
Dosing
· dose is 4-5 mg/kg over 60 min
· peak levels not required
· level at 18 hrs to check trough